This demonstrates the role of deficient UGT1A1 activity due to the presence of the homozygous variant genotype (UGT1A1*6/*28 or *6/*6) in the occurrence of severe neutropenia caused by the treatment of gynecological conditions with a low-dose CPT-11 regimen. The gene discussed is UGT1A1; the disease is Decreased total neutrophil count.